Acute kidney injury signals a high risk of death, readmission and cancer
Internal Medicine Journal · 2026
DOI: 10.1111/imj.70301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2026. Verfasst von Zena Barakat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Renal Medicine, Northern Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Acute Kidney Injury, Patient Readmission, Neoplasms. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Northern Health Foundation.
Abstract (Originalsprache)
Background
Incidence estimates of acute kidney injury ( AKI ) in Australia are frequently based on episodes of admitted care. Jurisdiction‐wide patient‐level linked analysis can better define the epidemiology of AKI .
Aims
Outline the incidence and prevalence of AKI and the outcomes associated with an admission complicated by AKI .
Methods
Retrospective data‐linkage analysis using the Victorian Death Index, Cancer Registry, Integrated Non‐Admitted Health and Admitted Episode datasets, examining adult, acute, overnight inpatient admissions in Victoria, Australia from July 2016 to June 2017. AKI episodes were identified using ICD ‐10‐ AM codes. The initial AKI episode marked the index admission, with a 36‐month look‐back and 36‐month follow‐up for comorbidity and outcomes. Primary outcomes were the incidence and prevalence of AKI . Secondary analyses examined readmission rates, the development of new morbidity and mortality, including causes of death.
Results
The incidence of AKI was 10.8% (95% confidence interval (CI): 10.7%–10.8%), with higher rates in the elderly, overseas‐born and comorbid patients. The prevalence of AKI was 1.1 cases per 100 annually. The inpatient mortality rate was 5.2% and was associated with Indigenous status (odds ration ( OR) 1.81, 95% CI: 1.31–2.50), higher comorbidity burden ( OR 3.97, 95% CI: 3.46–4.55), age ≥ 65 ( OR 1.24, 95% CI: 1.07–1.43) and aged care facility residence ( OR 2.32, 95% CI: 1.81–2.98). Among survivors of an index admission, 70.4% were readmitted within 12 months and 43.3% experienced recurrent AKI . Mortality was 23.2% at 12 months and 39.8% at 36 months, primarily attributed to cancer (26.0%) and cardiovascular disease (20.8%).
Conclusions
This jurisdiction‐wide, patient‐level study demonstrates a high prevalence of AKI , incidence and mortality, highlighting it as a public health issue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Renal Medicine, Northern Health, Melbourne, Victoria, Australia.
- Tasmanian School of Medicine, University of Tasmania, Hobart, Tasmania, Australia.
- Menzies Institute for Medical Research, Hobart, Tasmania, Australia.
- Department of Medicine (Melbourne Health and Northern Health), Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia.
- Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia.
- Department of Critical Care, School of Medicine, University of Melbourne, Parkville, Victoria, Australia.
ORCID-Profile: Zena Barakat, Timothy Pianta
Förderung
- Northern Health Foundation
Zitieren
APA
Barakat, Z., Jose, M., Savige, J., Bellomo, R., & Pianta, T. (2026). Acute kidney injury signals a high risk of death, readmission and cancer. Internal Medicine Journal. https://doi.org/10.1111/imj.70301
Vancouver
Barakat Z, Jose M, Savige J, Bellomo R, Pianta T. Acute kidney injury signals a high risk of death, readmission and cancer. Internal Medicine Journal. 2026. doi:10.1111/imj.70301
BibTeX
@article{Barakat2026,
author = {Barakat, Zena and Jose, Matthew and Savige, Judith and Bellomo, Rinaldo and Pianta, Timothy},
title = {Acute kidney injury signals a high risk of death, readmission and cancer},
journal = {Internal Medicine Journal},
year = {2026},
doi = {10.1111/imj.70301}
}
EUVIMED